“…Magnetic resonance spectroscopy (MRS) can be used to estimate individual differences in key neurochemical concentrations in local brain regions (Blüml and Panigrahy, 2012). It has been used to quantify neurochemical changes in neurological and neuropsychiatric disorders, such as Alzheimer’s disease (Wang et al, 2015), frontotemporal lobar degeneration-related syndromes (Murley et al, 2020, Murley et al, 2022), and schizophrenia (Jelen et al, 2018, Cohen et al, 2015, Duarte and Xin, 2019), as well as normal aging (Boumezbeur et al, 2010). Such spectroscopy can be predictive of task performance and the response to pharmacological interventions (Chowdhury et al, 2012, Stagg et al, 2011, McColgan et al, 2020, Gawne et al, 2020, Schmitz et al, 2017, Adams et al, 2021).…”